cellcentric.com
CellCentric - Epigenetics - developing small molecule inhibitors for cancerCellCentric is a drug discovery company developing small molecule inhibitors for cancer.
http://www.cellcentric.com/
CellCentric is a drug discovery company developing small molecule inhibitors for cancer.
http://www.cellcentric.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
1.5 seconds
16x16
Little●●●●●●erford , Cambridge, CB10 1XL
GB
View this contact
Little●●●●●●erford , Cambridge, CB10 1XL
GB
View this contact
Little●●●●●●erford , Cambridge, CB10 1XL
GB
View this contact
Little●●●●●●erford , Cambridge, CB10 1XL
GB
View this contact
BUY YOUR DOMAIN
21
YEARS
5
MONTHS
24
DAYS
REGISTRATION TECHNOLOGIES, INC.
WHOIS : whois.registrationtek.com
REFERRED : http://www.registrationtek.com
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
7
SITE IP
178.62.80.113
LOAD TIME
1.454 sec
SCORE
6.2
CellCentric - Epigenetics - developing small molecule inhibitors for cancer | cellcentric.com Reviews
https://cellcentric.com
CellCentric is a drug discovery company developing small molecule inhibitors for cancer.
cellcentric.com
CellCentric - Epigenetics - developing small molecule inhibitors for cancer
http://www.cellcentric.com/index.php
CellCentric develops novel small molecule inhibitors to combat cancer. Focusing on the androgen receptor pathway to treat the aggressive form of prostate cancer. A team with deep experience and proven track record in drug discovery and development. CellCentric expands team to push forward to IND. CellCentric secures funding to take its prostate cancer programme to IND. A beautiful afternoon in Cambridge MA. Thorough and positive full data review today - many thanks to RSChem for hosting.
Meet the team – CellCentric - Epigenetics - developing small molecule inhibitors for cancer
http://www.cellcentric.com/board.php
CellCentric’s leadership team has deep experience of drug discovery and development, as well as business collaboration. Executive Chairman and Board Member. Research Director and Board Member. Director, Translational Science. Finance Officer and Company Secretary. Investor Director and Board Member. Designed and built by Onespacemedia.
CellCentric programmes – CellCentric - Epigenetics - developing small molecule inhibitors for cancer
http://www.cellcentric.com/lead-programmes.php
CellCentric is focused on modulators of the androgen receptor pathway, drawing on its background of knowledge of epigenetic-related targets. Castrate Resistant Prostate Cancer. The development of CRPC is dependent upon the presence of a functional androgen receptor (AR). CellCentric’s pre-clinical inhibitors lower the levels of the AR in prostate cancer cells. Importantly these inhibitors also lower AR-splice variants, a key adaptation that drives resistance to current therapeutic agents. CellCentric’s e...
CellCentric programmes – CellCentric - Epigenetics - developing small molecule inhibitors for cancer
http://www.cellcentric.com/epigenetic-targets.php
CellCentric is focused on modulators of the androgen receptor pathway, drawing on its background of knowledge of epigenetic-related targets. Castrate Resistant Prostate Cancer. The development of CRPC is dependent upon the presence of a functional androgen receptor (AR). CellCentric’s pre-clinical inhibitors lower the levels of the AR in prostate cancer cells. Importantly these inhibitors also lower AR-splice variants, a key adaptation that drives resistance to current therapeutic agents. CellCentric’s e...
News – CellCentric - Epigenetics - developing small molecule inhibitors for cancer
http://www.cellcentric.com/press-releases.php
Press Releases and Tweets (follow @cellcentric) issued by the company. CellCentric expands team to push forward to IND. CellCentric is developing proprietary anti-cancer compounds that target androgen receptor (AR) regulation. These hold promise for castrate resistant prostate cancer (CRPC) as well as other cancers. As the company moves towards Candidate selection and IND qualification, CellCentric is expanding its team for future activities. CellCentric successfully completes InnovateUK programme. A Eur...
TOTAL PAGES IN THIS WEBSITE
6
Equity portfolio - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/industry/equity-portfolio/c/vivamer-ltd
How we can help. Clinical and Biomedical Computing. Image: The Old Schools, courtesy the University of Cambridge. Industry, government and non-profits. Academics, researchers and students. Clubs, programmes and networking. Follow us on Twitter. Join our LinkedIn group. Healthera secures investment from Cambridge Enterprise. 17th August, 2016. Robot-assisted surgery closer as Cambridge Medical Robotics raises $20m. 18th July, 2016. 29th June, 2016. 29th June, 2016. Sign up to our Newsletter.
Takeda Ventures, Inc. > TVI Portfolio
http://www.takedaventures.com/portfolio
Skip to main content. ArmaGen, Inc (CA, USA). Has developed a receptor transcytosis Trojan Horse technology platform enabling non-invasive delivery of biotherapeutics across the blood-brain barrier. The company is initially focusing on treatment of lysosomal storage diseases, where CNS involvement cannot be addressed by current standards of care. CellCentric, Ltd. (Cambridge, UK). Domainex, Ltd (Cambridge, UK). Encycle Therapeutics, Inc. (ON, Canada). Is pioneering the development of nacellins, small cyc...
conference.cambridgephenomenon.com
Competition - The Cambridge Phenomenon Conference
http://www.conference.cambridgephenomenon.com/competition-videos
Enter our draw to WIN a copy of the Cambridge Phenomenon book. Connect with us on. As part of The Future Starts Here. Cambridge Phenomenon Ltd, in partnership with Microsoft Research, ARM and Price Bailey, ran a competition to identify the most exciting companies of the future in IT and Biosciences. The winners were selected by the delegates at the end of the conference using real–time electronic voting. Cambridge Phenomenon Award 2010. Click on a video to watch the company pitches. Develops products bas...
New Economy Hides a Radical Change | About Growing Entrepreneurial Businesses
https://growingbusiness.wordpress.com/2009/10/20/new-economy-hides-a-radical-change
About Growing Entrepreneurial Businesses. Dynamic content on all matters to do with growing businesses from Keith Willey. October 20, 2009 • 5:19 pm. New Economy Hides a Radical Change. It seems there’s gathering momentum that a New Economy will emerge in the UK post the financial sector meltdown and it will be based on manufacturing – that was the message I took from a Policy Exchange. Clark demonstrated great mastery of his brief and offered thoughts on what might be done about things. Meanwhile I can&...
Cheer Squad for Venture Capital | About Growing Entrepreneurial Businesses
https://growingbusiness.wordpress.com/2009/10/08/cheer-squad-for-venture-capital
About Growing Entrepreneurial Businesses. Dynamic content on all matters to do with growing businesses from Keith Willey. October 8, 2009 • 11:12 am. Cheer Squad for Venture Capital. Forgot to note the very encouraging turnout for the 23 September Investor Allstars. Event at the Hilton Park Lane. This event has for me been a bellweather for how the entrepreneurial space is doing: in the past attendance has oscillated from the small and depressed (post tech bust! Business XL PER recruitment. A1 Technologi...
Fruits of their Labours | About Growing Entrepreneurial Businesses
https://growingbusiness.wordpress.com/2009/11/10/fruits-of-their-labours
About Growing Entrepreneurial Businesses. Dynamic content on all matters to do with growing businesses from Keith Willey. November 10, 2009 • 10:02 am. Fruits of their Labours. This is an update to an earlier post. And Admob respectively. Well what do you know? Both businesses got bought in the last couple of weeks. Research Now! Went for around 85m in a sale. 8217;s case it’s not necessarily an exit itself. Leave a Reply Cancel reply. Enter your comment here. Address never made public). You are commenti...
TOTAL LINKS TO THIS WEBSITE
7
[DEV SITE]Free Night of Theatre
LA STAGE Free Night of Theater. LA STAGE Alliance is a 501 (c) (3) non profit organization dedicated to building awareness, appreciation and support for the performing arts in Greater Los Angeles through community building, collaborative marketing, audience development, professional development to strengthen operations for members and advocacy. Free Night of Theater is a national program, created and supported by Theater Communications Group (TCG), the national organization for the American Theatre.
CellCentives
cellcentralamerica.blogspot.com
CELL Central America Semester Program 2008
CELL Central America Semester Program 2008. We at CELL offer life-changing abroad programs about Sustainability through Community for college students interested in being a part of the change toward environmental, community, and global sustainability. Saturday, May 3, 2008. CELL Central America Semester Program Blog. 4, 2008, we completed a three month/three country (Nicaragua, Honduras, and Costa Rica) semester program focusing on a theme of ". Oluntary Simplicity, Choices for Sustainability,. By seeing...
cellcentralamerica2012.blogspot.com
CELL Central America Program 2012
CELL Central America Program 2012. Unique Study Abroad program in Central America focused on a theme of "sustainability through community.". Friday, April 6, 2012. Courtney in Copan, three months ago. As someone who has Sustainable Community Development as one of their majors, I feel like I should have a better conception of what sustainable communities are or should be. I guess I understand it at a theoretical level, but I don’t think I had ever seen an example of a healthy, functioning sustai...The fir...
cellcentre.com -
CellCentric - Epigenetics - developing small molecule inhibitors for cancer
CCS1477, a first-in-class small molecule to treat prostate (CRPC) and other cancers. P300/CBP bromodomain inhibitor CCS1477. CCS1477 inhibits the bromodomains of twin histone acetyl transferase proteins, p300/CBP. There is a large and growing population of prostate cancer patients that are resistant to second generation anti-hormonal drugs. CCS1477 addresses this through lowering the key drivers of this resistance and late stage disease: AR, AR-SV and c-Myc. AACR-Prostate, Orlando (2017). A novel small m...
CellCept® (mycophenolate mofetil) Patient Information
For US Healthcare Professionals. For Patients and Caregivers. For US Healthcare Professionals. For Patients and Caregivers. CellCept $15 Co-pay Card. Be sure to get the medicine you were prescribed. Learn how to identify brand-name CellCept. Review patient assistance options. Find out about assistance options that can help you pay for CellCept, based on your eligibility. IMPORTANT SAFETY INFORMATION and INDICATION. WHO IS CELLCEPT FOR? WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT CELLCEPT?
CELLCEPT- CZY JESTEŚ ZA ?
Poszukuję osób znających języki obce,do pomocy w redagowaniu tego serwisu. więcej. Jeżeli jesteś webmasterem,możesz pomóc w Naszej Akcji,pobierając Nasz banner . więcej. Do wszystkich,którzy oddali już swój głos,oraz do . PRZECZYTAJ OPINIE LUDZI ZE ŚRODOWISKA. Jeśli znajdziesz interesujący artykuł lub pracę,to czekam na kontakt. My, chorzy na nieuleczalną chorobę - TOCZEŃ , postulujemy , aby leczenie tej choroby lekiem o nazwie. Było uznane za standard . Dlaczego My jesteśmy pozbawieni tej możliwości?
cellceptlawsuit.com - cellceptlawsuit Resources and Information.
The owner of cellceptlawsuit.com. Is offering it for sale for an asking price of 449 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Cellcert.com
cellcessories.com
This domain is available for sale. To purchase, call Afternic at 1 781-314-9607 or 844-886-1722. Click here to inquire.
SOCIAL ENGAGEMENT